Status:
UNKNOWN
Role of Information and Communication Technologies for Health Support in Inflammatory Bowel Diseases: The DAMASCO Trial
Lead Sponsor:
Hospital Nacional Profesor Alejandro Posadas
Collaborating Sponsors:
Hospital Nacional Cayetano Heredia
Instituto Ecuatoriano de Enfermedades Digestivas
Conditions:
Inflammatory Bowel Diseases
Knowledge, Attitudes, Practice
Eligibility:
All Genders
15-79 years
Brief Summary
In Latin America, inadequate treatment adherence and compliance in IBD patients is around 64% in Brazilians, 54.4% in Mexicans and 50.3% in Argentinians. In industrialised countries, it has been descr...
Detailed Description
State of the Art: A chronic condition with a particular approach but also with an unpredictable course difficult treatment adherence and compliance is seen among Inflammatory Bowel Diseases (IBD) pat...
Eligibility Criteria
Inclusion
- Every patient ≥15 years old;
- Patients attended by a Gastroenterology consultation;
- Patients attended due to an established diagnosis of Crohn's disease, ulcerative colitis, indeterminate colitis or IBD unclassified;
- Patients whose diagnosis should be based on Lennard-Jonnes criteria: clinical, imaging, endoscopic or anatomopathological findings.
Exclusion
- Patients with a recent diagnosis and no more than a 6-months follow-up;
- Patients ongoing hospitalisation due to severe IBD flare;
- Patients with psychiatric diseases, language impairment, those who find it difficult to visualise the survey or any other condition that difficult answering of a self-administered survey;
- Patients who they are sanitary professional will not be considered for disease-related knowledge level evaluation;
- Patients not under pharmacological treatment (as naïve patients) will not be considered for treatment adherence and compliance evaluation
Key Trial Info
Start Date :
May 3 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2022
Estimated Enrollment :
351 Patients enrolled
Trial Details
Trial ID
NCT04893928
Start Date
May 3 2021
End Date
April 30 2022
Last Update
May 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Miguel Angel Puga Tejada
Buenos Aires, Argentina, 1076